{"id":"W3035514338","doi":"10.3233/jnd-200534","title":"Measuring Outcomes in Adults with Spinal Muscular Atrophy – Challenges and Future Directions – Meeting Report","year":2020,"lang":"en","type":"article","venue":"Journal of Neuromuscular Diseases","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; Children's Hospital of Eastern Ontario; University of Ottawa","funders":"Audentes Therapeutics; Sarepta Therapeutics; GW Pharmaceuticals; Ionis Pharmaceuticals; Sanofi; PTC Therapeutics; Ultragenyx Pharmaceutical; CSL Behring; AveXis; Biogen; Alnylam Pharmaceuticals; Alexion Pharmaceuticals; Pfizer","keywords":"SMN1; Spinal muscular atrophy; SMA*; Medicine; Motor neuron; Neuromuscular disease; Clinical trial; Population; Disease; Quality of life (healthcare); Physical medicine and rehabilitation; Bioinformatics; Physical therapy; Internal medicine; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001654624,0.0002205224,0.0005696582,0.0002303715,0.0000733705,0.0000275227,0.0001173735,0.00005268203,0.0000108496],"category_scores_gemma":[0.0004299988,0.0001583466,0.0003202442,0.0002511832,0.00008338789,0.0001332123,0.00006162947,0.0003981433,0.000001281417],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002299352,"about_ca_system_score_gemma":0.0001610053,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007050066,"about_ca_topic_score_gemma":0.000007610969,"domain_scores_codex":[0.9978805,0.0001549328,0.000473921,0.0003535371,0.000862458,0.000274662],"domain_scores_gemma":[0.9987109,0.00003735759,0.0002224778,0.0002409077,0.0002396475,0.0005486545],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00763076,0.002103069,0.7086706,0.004174373,0.00163092,0.08365477,0.002519246,0.0001676282,0.005412271,0.00006342588,0.0001007096,0.1838722],"study_design_scores_gemma":[0.003647358,0.001957677,0.9778807,0.0005470482,0.000397554,0.002801886,0.001257413,0.0000496543,0.0001004994,0.00001534315,0.01115906,0.0001857953],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9218111,0.06521279,0.00001914237,0.01235277,0.00008563737,0.0003262332,0.000002240547,0.00002370646,0.0001663702],"genre_scores_gemma":[0.9715563,0.02726575,0.0003529096,0.0003147952,0.0004452787,0.00001057289,0.000002072401,0.0000451582,0.000007187145],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2692101,"threshold_uncertainty_score":0.6457186,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03291156471814895,"score_gpt":0.2714065526890334,"score_spread":0.2384949879708844,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}